Q-omics provides the consensus-scored RNU2-23P profile across patient tissues and cancer cell-line models. RNU2-23P expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, RNU2-23P RNA expression shows 6,239 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight BLCA, and THYM as cancer lineages where RNU2-23P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNU2-23P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNU2-23P survival associations across molecular data types. RNU2-23P RNA expression shows survival associations in the most cancer types (9). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU2-23P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	9	BLCA (144)	view →

This table ranks reproducible RNU2-23P RNA expression–survival associations across cancer types. High RNU2-23P expression shows unfavorable associations in BLCA, BRCA, UCS, PAAD and ACC, but favorable associations in ESCA. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for RNU2-23P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	IV	0.146	0.597	<.001	144	view →
BRCA	DFS	Tertile	II,III,IV	0.788	0.893	.011	42	view →
UCS	DFS	Tertile	III,IV	0.103	0.455	.001	36	view →
PAAD	OS	Tertile	All	0.163	0.547	.007	36	view →
ACC	DFS	Tertile	II,III,IV	0.066	0.631	.005	18	view →
ESCA	OS	Tertile	III,IV	0.601	0.340	.046	18	view →

Pink = unfavorable, green = favorable. all 9 lineages →

RNU2-23P-BLCA (OS)

Kaplan–Meier survival curve for RNU2-23P RNA expression in BLCA: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNU2-23P in patient tissues and cancer cell lines. In patient samples, RNU2-23P shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	6,239	THYM (2584)	view →
Function (RNA)	5,900	STAD (5539)	view →